{"id":"NCT02994927","sponsor":"Amgen","briefTitle":"A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis","officialTitle":"A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-03-15","primaryCompletion":"2019-09-07","completion":"2019-11-01","firstPosted":"2016-12-16","resultsPosted":"2022-09-09","lastUpdate":"2025-03-24"},"enrollment":331,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["ANCA-Associated Vasculitis"],"interventions":[{"type":"DRUG","name":"Avacopan","otherNames":["CCX168"]},{"type":"DRUG","name":"Prednisone","otherNames":[]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":[]},{"type":"BIOLOGICAL","name":"Rituximab","otherNames":[]},{"type":"DRUG","name":"Azathioprine","otherNames":[]}],"arms":[{"label":"Prednisone group","type":"ACTIVE_COMPARATOR"},{"label":"Avacopan group","type":"EXPERIMENTAL"}],"summary":"The primary objective is to evaluate the efficacy of CCX168 (avacopan) to induce and sustain remission in patients with active anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), when used in combination with cyclophosphamide followed by azathioprine, or in combination with rituximab.","primaryOutcome":{"measure":"Percentage of Subjects Achieving Disease Remission at Week 26","timeFrame":"Week 26","effectByArm":[{"arm":"Prednisone Group","deltaMin":70.1,"sd":null},{"arm":"Avacopan Group","deltaMin":72.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"},{"comp":"OG000 vs OG001","p":"= 0.2387"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":11},"locations":{"siteCount":198,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","Denmark","France","Germany","Hungary","Ireland","Italy","Japan","Netherlands","New Zealand","Norway","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["37979959","35167187","33596356","32088663"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":74,"n":164},"commonTop":["Oedema peripheral","Nausea","Arthralgia","Anti-neutrophil cytoplasmic antibody positive vasculitis","Hypertension"]}}